PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+35.59%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$9.28B
AUM Growth
+$9.28B
Cap. Flow
+$1.17B
Cap. Flow %
12.62%
Top 10 Hldgs %
43.31%
Holding
162
New
36
Increased
23
Reduced
15
Closed
21

Top Buys

1
NVTA
Invitae Corporation
NVTA
$305M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$226M
3
AVIR icon
Atea Pharmaceuticals
AVIR
$130M
4
CCCC icon
C4 Therapeutics
CCCC
$105M
5
KRON
Kronos Bio
KRON
$83M

Top Sells

1
MYOK
MyoKardia, Inc. Common Stock
MYOK
$190M
2
CRSP icon
CRISPR Therapeutics
CRSP
$112M
3
IMMU
Immunomedics Inc
IMMU
$77.6M
4
BPMC
Blueprint Medicines
BPMC
$61.6M
5
COGT icon
Cogent Biosciences
COGT
$53.5M

Sector Composition

1 Healthcare 85.79%
2 Industrials 0.29%
3 Materials 0.22%
4 Financials 0.13%
5 Consumer Discretionary 0.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCVX icon
76
Vaxcyte
PCVX
$4.19B
$22.6M 0.24%
850,000
– –
GERN icon
77
Geron
GERN
$925M
$21.4M 0.23%
13,461,538
– –
PNT
78
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$20.9M 0.22%
1,500,000
– –
AMRS
79
DELISTED
Amyris Inc.
AMRS
$20.6M 0.22%
3,333,332
– –
VRNA
80
Verona Pharma
VRNA
$9.18B
$20.2M 0.22%
2,888,889
– –
WVE icon
81
Wave Life Sciences
WVE
$1.26B
$19.7M 0.21%
2,500,000
– –
LPTX icon
82
Leap Therapeutics
LPTX
$12.5M
$19.1M 0.2%
8,476,496
– –
VTRS icon
83
Viatris
VTRS
$12.3B
$18.8M 0.2%
1,004,419
– –
RGEN icon
84
Repligen
RGEN
$6.75B
$18.7M 0.2%
+97,500
New +$18.7M
SCYX icon
85
SCYNEXIS
SCYX
$34.9M
$18.4M 0.2%
+2,400,000
New +$18.4M
HRMY icon
86
Harmony Biosciences
HRMY
$2.13B
$18.2M 0.2%
502,622
+67,245
+15% +$2.43M
NBTX
87
Nanobiotix
NBTX
$422M
$18.2M 0.19%
+1,100,000
New +$18.2M
DRNA
88
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$17.6M 0.19%
800,000
– –
DBVT
89
DBV Technologies
DBVT
$251M
$17.3M 0.19%
6,595,505
-211,470
-3% -$554K
CTMX icon
90
CytomX Therapeutics
CTMX
$348M
$16.9M 0.18%
2,577,043
– –
MORF
91
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$16.3M 0.18%
487,000
– –
LGVW.U
92
DELISTED
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
$15.2M 0.16%
700,000
– –
TARA icon
93
Protara Therapeutics
TARA
$126M
$14.7M 0.16%
608,544
– –
AMWL icon
94
American Well
AMWL
$109M
$13.3M 0.14%
525,000
+70,000
+15% +$1.77M
FBRX icon
95
Forte Biosciences
FBRX
$138M
$12.7M 0.14%
+350,000
New +$12.7M
TSHA icon
96
Taysha Gene Therapies
TSHA
$786M
$12.5M 0.13%
470,440
– –
TCRR
97
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$12.4M 0.13%
400,000
– –
HCAT icon
98
Health Catalyst
HCAT
$233M
$12M 0.13%
276,084
-15,000
-5% -$653K
BLSA
99
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$11.1M 0.12%
+1,000,000
New +$11.1M
SCPE.U
100
DELISTED
SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o
SCPE.U
$11M 0.12%
1,000,000
– –
2 3
4
5 6